MEDICINE 润色咨询

medicine

出版年份：1922 年文章数：38863 投稿命中率： 开通期刊会员，数据随心看

出版周期：Bimonthly 自引率：6.8% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2204952, encodeId=be1822049529e, content=偏重的研究方向：Meta分析<br>经验分享：Under review两个月了，还没有一点消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00c59089313, createdName=科研狂人系列, createdTime=Thu May 16 01:34:54 CST 2024, time=2024-05-16, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2161362, encodeId=0b2e216136223, content=偏重的研究方向：肿瘤;case report<br>经验分享：大家的文章在编辑手里待了多久啊，我with editor已经两个多月了。。。别说发表了，连审稿人手都到不了啊，感觉好慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1868855082, createdName=ms8000002119425457, createdTime=Sat Oct 07 16:08:13 CST 2023, time=2023-10-07, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2207103, encodeId=fd42220e10338, content=偏重的研究方向：肿瘤<br>经验分享：细胞或基础实验可以投Medicine吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63569074657, createdName=ms2000000266526934, createdTime=Tue May 28 19:44:36 CST 2024, time=2024-05-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2205315, encodeId=5ef0220531597, content=偏重的研究方向：综合<br>经验分享：Medicine 已见刊 已提交proof 还可以改一点内容吗。不涉及修改数据 就是改一下位置。 就是解释曲线的时候两个指标的生存率写反了。 有人改过吗？medicine是什么态度？<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a><a href='/topic/show?id=cda91148004' target=_blank style='color:#2F92EE;'>#Medicine#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=11480, encryptionId=cda91148004, topicName=Medicine), TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ef29236849, createdName=ms9000001613493042, createdTime=Sat May 18 02:56:29 CST 2024, time=2024-05-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2195248, encodeId=723c219524857, content=medicine返修以后还会拒稿吗，我是OA revise，现在已经with editor快1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=448d5485741, createdName=X.Dawn, createdTime=Mon Mar 25 16:04:17 CST 2024, time=2024-03-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2163624, encodeId=7b2f2163624bc, content=请问各位大佬 这个杂志大概好久能收到proof啊 我10.7号交了版面费 到现在也没有收到proof 有相似情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab278177983, createdName=ms8000001025994613, createdTime=Wed Oct 18 22:27:29 CST 2023, time=2023-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170663, encodeId=07ae21e06633f, content=审稿速度:6.0<br>偏重的研究方向：SEER数据库<br>经验分享：文章接收了，给大家分享一下投稿历程<br>2023-06-27 Submit<br>2023-06-28 Under review 中间时间变过3次，4个审稿人<br>2023-09-28 required reviews completed<br>2023-10-04 required reviews completed<br>2023-10-09 required reviews completed<br>2023-10-09 required reviews completed<br>2023-10-10 With Editor<br>2023-10-17 Revise <br>2023-10-30 Revision submitted<br>2023-11-01 With editor<br>2023-11-14 Under review<br>2023-11-24 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73c18483515, createdName=ms8000001640264275, createdTime=Fri Nov 24 09:14:06 CST 2023, time=2023-11-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2194651, encodeId=513d2194651d7, content=请问一下具体的审稿流程，我两个月还在Under Review是没戏了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7e59151108, createdName=ms1000000549465605, createdTime=Fri Mar 22 10:41:04 CST 2024, time=2024-03-22, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2167951, encodeId=258d216e9519b, content=偏重的研究方向：肿瘤<br>经验分享：proof上传之后发现还有地方想改动，可以申请再次proof吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd3c5461670, createdName=ms4000000998812163, createdTime=Sat Nov 11 08:06:25 CST 2023, time=2023-11-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2204874, encodeId=4df022048e459, content=with editor三个月，under review一个月，突然被拒，也不说明具体原因，真是让人无语，浪费时间！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=31495572765, createdName=ms2000001821297625, createdTime=Wed May 15 19:00:43 CST 2024, time=2024-05-15, status=1, ipAttribution=山东省)]
    2024-05-16 科研狂人系列 来自福建省

    偏重的研究方向：Meta分析
    经验分享：Under review两个月了，还没有一点消息

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2204952, encodeId=be1822049529e, content=偏重的研究方向：Meta分析<br>经验分享：Under review两个月了，还没有一点消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00c59089313, createdName=科研狂人系列, createdTime=Thu May 16 01:34:54 CST 2024, time=2024-05-16, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2161362, encodeId=0b2e216136223, content=偏重的研究方向：肿瘤;case report<br>经验分享：大家的文章在编辑手里待了多久啊，我with editor已经两个多月了。。。别说发表了，连审稿人手都到不了啊，感觉好慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1868855082, createdName=ms8000002119425457, createdTime=Sat Oct 07 16:08:13 CST 2023, time=2023-10-07, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2207103, encodeId=fd42220e10338, content=偏重的研究方向：肿瘤<br>经验分享：细胞或基础实验可以投Medicine吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63569074657, createdName=ms2000000266526934, createdTime=Tue May 28 19:44:36 CST 2024, time=2024-05-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2205315, encodeId=5ef0220531597, content=偏重的研究方向：综合<br>经验分享：Medicine 已见刊 已提交proof 还可以改一点内容吗。不涉及修改数据 就是改一下位置。 就是解释曲线的时候两个指标的生存率写反了。 有人改过吗？medicine是什么态度？<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a><a href='/topic/show?id=cda91148004' target=_blank style='color:#2F92EE;'>#Medicine#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=11480, encryptionId=cda91148004, topicName=Medicine), TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ef29236849, createdName=ms9000001613493042, createdTime=Sat May 18 02:56:29 CST 2024, time=2024-05-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2195248, encodeId=723c219524857, content=medicine返修以后还会拒稿吗，我是OA revise，现在已经with editor快1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=448d5485741, createdName=X.Dawn, createdTime=Mon Mar 25 16:04:17 CST 2024, time=2024-03-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2163624, encodeId=7b2f2163624bc, content=请问各位大佬 这个杂志大概好久能收到proof啊 我10.7号交了版面费 到现在也没有收到proof 有相似情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab278177983, createdName=ms8000001025994613, createdTime=Wed Oct 18 22:27:29 CST 2023, time=2023-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170663, encodeId=07ae21e06633f, content=审稿速度:6.0<br>偏重的研究方向：SEER数据库<br>经验分享：文章接收了，给大家分享一下投稿历程<br>2023-06-27 Submit<br>2023-06-28 Under review 中间时间变过3次，4个审稿人<br>2023-09-28 required reviews completed<br>2023-10-04 required reviews completed<br>2023-10-09 required reviews completed<br>2023-10-09 required reviews completed<br>2023-10-10 With Editor<br>2023-10-17 Revise <br>2023-10-30 Revision submitted<br>2023-11-01 With editor<br>2023-11-14 Under review<br>2023-11-24 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73c18483515, createdName=ms8000001640264275, createdTime=Fri Nov 24 09:14:06 CST 2023, time=2023-11-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2194651, encodeId=513d2194651d7, content=请问一下具体的审稿流程，我两个月还在Under Review是没戏了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7e59151108, createdName=ms1000000549465605, createdTime=Fri Mar 22 10:41:04 CST 2024, time=2024-03-22, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2167951, encodeId=258d216e9519b, content=偏重的研究方向：肿瘤<br>经验分享：proof上传之后发现还有地方想改动，可以申请再次proof吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd3c5461670, createdName=ms4000000998812163, createdTime=Sat Nov 11 08:06:25 CST 2023, time=2023-11-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2204874, encodeId=4df022048e459, content=with editor三个月，under review一个月，突然被拒，也不说明具体原因，真是让人无语，浪费时间！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=31495572765, createdName=ms2000001821297625, createdTime=Wed May 15 19:00:43 CST 2024, time=2024-05-15, status=1, ipAttribution=山东省)]
    2023-10-07 ms8000002119425457 来自山西省

    偏重的研究方向：肿瘤;case report
    经验分享：大家的文章在编辑手里待了多久啊，我with editor已经两个多月了。。。别说发表了，连审稿人手都到不了啊，感觉好慢

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2204952, encodeId=be1822049529e, content=偏重的研究方向：Meta分析<br>经验分享：Under review两个月了，还没有一点消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00c59089313, createdName=科研狂人系列, createdTime=Thu May 16 01:34:54 CST 2024, time=2024-05-16, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2161362, encodeId=0b2e216136223, content=偏重的研究方向：肿瘤;case report<br>经验分享：大家的文章在编辑手里待了多久啊，我with editor已经两个多月了。。。别说发表了，连审稿人手都到不了啊，感觉好慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1868855082, createdName=ms8000002119425457, createdTime=Sat Oct 07 16:08:13 CST 2023, time=2023-10-07, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2207103, encodeId=fd42220e10338, content=偏重的研究方向：肿瘤<br>经验分享：细胞或基础实验可以投Medicine吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63569074657, createdName=ms2000000266526934, createdTime=Tue May 28 19:44:36 CST 2024, time=2024-05-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2205315, encodeId=5ef0220531597, content=偏重的研究方向：综合<br>经验分享：Medicine 已见刊 已提交proof 还可以改一点内容吗。不涉及修改数据 就是改一下位置。 就是解释曲线的时候两个指标的生存率写反了。 有人改过吗？medicine是什么态度？<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a><a href='/topic/show?id=cda91148004' target=_blank style='color:#2F92EE;'>#Medicine#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=11480, encryptionId=cda91148004, topicName=Medicine), TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ef29236849, createdName=ms9000001613493042, createdTime=Sat May 18 02:56:29 CST 2024, time=2024-05-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2195248, encodeId=723c219524857, content=medicine返修以后还会拒稿吗，我是OA revise，现在已经with editor快1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=448d5485741, createdName=X.Dawn, createdTime=Mon Mar 25 16:04:17 CST 2024, time=2024-03-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2163624, encodeId=7b2f2163624bc, content=请问各位大佬 这个杂志大概好久能收到proof啊 我10.7号交了版面费 到现在也没有收到proof 有相似情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab278177983, createdName=ms8000001025994613, createdTime=Wed Oct 18 22:27:29 CST 2023, time=2023-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170663, encodeId=07ae21e06633f, content=审稿速度:6.0<br>偏重的研究方向：SEER数据库<br>经验分享：文章接收了，给大家分享一下投稿历程<br>2023-06-27 Submit<br>2023-06-28 Under review 中间时间变过3次，4个审稿人<br>2023-09-28 required reviews completed<br>2023-10-04 required reviews completed<br>2023-10-09 required reviews completed<br>2023-10-09 required reviews completed<br>2023-10-10 With Editor<br>2023-10-17 Revise <br>2023-10-30 Revision submitted<br>2023-11-01 With editor<br>2023-11-14 Under review<br>2023-11-24 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73c18483515, createdName=ms8000001640264275, createdTime=Fri Nov 24 09:14:06 CST 2023, time=2023-11-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2194651, encodeId=513d2194651d7, content=请问一下具体的审稿流程，我两个月还在Under Review是没戏了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7e59151108, createdName=ms1000000549465605, createdTime=Fri Mar 22 10:41:04 CST 2024, time=2024-03-22, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2167951, encodeId=258d216e9519b, content=偏重的研究方向：肿瘤<br>经验分享：proof上传之后发现还有地方想改动，可以申请再次proof吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd3c5461670, createdName=ms4000000998812163, createdTime=Sat Nov 11 08:06:25 CST 2023, time=2023-11-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2204874, encodeId=4df022048e459, content=with editor三个月，under review一个月，突然被拒，也不说明具体原因，真是让人无语，浪费时间！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=31495572765, createdName=ms2000001821297625, createdTime=Wed May 15 19:00:43 CST 2024, time=2024-05-15, status=1, ipAttribution=山东省)]
    2024-05-28 ms2000000266526934 来自湖北省

    偏重的研究方向：肿瘤
    经验分享：细胞或基础实验可以投Medicine吗

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2204952, encodeId=be1822049529e, content=偏重的研究方向：Meta分析<br>经验分享：Under review两个月了，还没有一点消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00c59089313, createdName=科研狂人系列, createdTime=Thu May 16 01:34:54 CST 2024, time=2024-05-16, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2161362, encodeId=0b2e216136223, content=偏重的研究方向：肿瘤;case report<br>经验分享：大家的文章在编辑手里待了多久啊，我with editor已经两个多月了。。。别说发表了，连审稿人手都到不了啊，感觉好慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1868855082, createdName=ms8000002119425457, createdTime=Sat Oct 07 16:08:13 CST 2023, time=2023-10-07, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2207103, encodeId=fd42220e10338, content=偏重的研究方向：肿瘤<br>经验分享：细胞或基础实验可以投Medicine吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63569074657, createdName=ms2000000266526934, createdTime=Tue May 28 19:44:36 CST 2024, time=2024-05-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2205315, encodeId=5ef0220531597, content=偏重的研究方向：综合<br>经验分享：Medicine 已见刊 已提交proof 还可以改一点内容吗。不涉及修改数据 就是改一下位置。 就是解释曲线的时候两个指标的生存率写反了。 有人改过吗？medicine是什么态度？<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a><a href='/topic/show?id=cda91148004' target=_blank style='color:#2F92EE;'>#Medicine#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=11480, encryptionId=cda91148004, topicName=Medicine), TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ef29236849, createdName=ms9000001613493042, createdTime=Sat May 18 02:56:29 CST 2024, time=2024-05-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2195248, encodeId=723c219524857, content=medicine返修以后还会拒稿吗，我是OA revise，现在已经with editor快1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=448d5485741, createdName=X.Dawn, createdTime=Mon Mar 25 16:04:17 CST 2024, time=2024-03-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2163624, encodeId=7b2f2163624bc, content=请问各位大佬 这个杂志大概好久能收到proof啊 我10.7号交了版面费 到现在也没有收到proof 有相似情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab278177983, createdName=ms8000001025994613, createdTime=Wed Oct 18 22:27:29 CST 2023, time=2023-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170663, encodeId=07ae21e06633f, content=审稿速度:6.0<br>偏重的研究方向：SEER数据库<br>经验分享：文章接收了，给大家分享一下投稿历程<br>2023-06-27 Submit<br>2023-06-28 Under review 中间时间变过3次，4个审稿人<br>2023-09-28 required reviews completed<br>2023-10-04 required reviews completed<br>2023-10-09 required reviews completed<br>2023-10-09 required reviews completed<br>2023-10-10 With Editor<br>2023-10-17 Revise <br>2023-10-30 Revision submitted<br>2023-11-01 With editor<br>2023-11-14 Under review<br>2023-11-24 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73c18483515, createdName=ms8000001640264275, createdTime=Fri Nov 24 09:14:06 CST 2023, time=2023-11-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2194651, encodeId=513d2194651d7, content=请问一下具体的审稿流程，我两个月还在Under Review是没戏了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7e59151108, createdName=ms1000000549465605, createdTime=Fri Mar 22 10:41:04 CST 2024, time=2024-03-22, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2167951, encodeId=258d216e9519b, content=偏重的研究方向：肿瘤<br>经验分享：proof上传之后发现还有地方想改动，可以申请再次proof吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd3c5461670, createdName=ms4000000998812163, createdTime=Sat Nov 11 08:06:25 CST 2023, time=2023-11-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2204874, encodeId=4df022048e459, content=with editor三个月，under review一个月，突然被拒，也不说明具体原因，真是让人无语，浪费时间！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=31495572765, createdName=ms2000001821297625, createdTime=Wed May 15 19:00:43 CST 2024, time=2024-05-15, status=1, ipAttribution=山东省)]
    2024-05-18 ms9000001613493042 来自四川省

    偏重的研究方向：综合
    经验分享：Medicine 已见刊 已提交proof 还可以改一点内容吗。不涉及修改数据 就是改一下位置。 就是解释曲线的时候两个指标的生存率写反了。 有人改过吗？medicine是什么态度？#期刊论坛##Medicine#

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2204952, encodeId=be1822049529e, content=偏重的研究方向：Meta分析<br>经验分享：Under review两个月了，还没有一点消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00c59089313, createdName=科研狂人系列, createdTime=Thu May 16 01:34:54 CST 2024, time=2024-05-16, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2161362, encodeId=0b2e216136223, content=偏重的研究方向：肿瘤;case report<br>经验分享：大家的文章在编辑手里待了多久啊，我with editor已经两个多月了。。。别说发表了，连审稿人手都到不了啊，感觉好慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1868855082, createdName=ms8000002119425457, createdTime=Sat Oct 07 16:08:13 CST 2023, time=2023-10-07, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2207103, encodeId=fd42220e10338, content=偏重的研究方向：肿瘤<br>经验分享：细胞或基础实验可以投Medicine吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63569074657, createdName=ms2000000266526934, createdTime=Tue May 28 19:44:36 CST 2024, time=2024-05-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2205315, encodeId=5ef0220531597, content=偏重的研究方向：综合<br>经验分享：Medicine 已见刊 已提交proof 还可以改一点内容吗。不涉及修改数据 就是改一下位置。 就是解释曲线的时候两个指标的生存率写反了。 有人改过吗？medicine是什么态度？<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a><a href='/topic/show?id=cda91148004' target=_blank style='color:#2F92EE;'>#Medicine#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=11480, encryptionId=cda91148004, topicName=Medicine), TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ef29236849, createdName=ms9000001613493042, createdTime=Sat May 18 02:56:29 CST 2024, time=2024-05-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2195248, encodeId=723c219524857, content=medicine返修以后还会拒稿吗，我是OA revise，现在已经with editor快1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=448d5485741, createdName=X.Dawn, createdTime=Mon Mar 25 16:04:17 CST 2024, time=2024-03-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2163624, encodeId=7b2f2163624bc, content=请问各位大佬 这个杂志大概好久能收到proof啊 我10.7号交了版面费 到现在也没有收到proof 有相似情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab278177983, createdName=ms8000001025994613, createdTime=Wed Oct 18 22:27:29 CST 2023, time=2023-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170663, encodeId=07ae21e06633f, content=审稿速度:6.0<br>偏重的研究方向：SEER数据库<br>经验分享：文章接收了，给大家分享一下投稿历程<br>2023-06-27 Submit<br>2023-06-28 Under review 中间时间变过3次，4个审稿人<br>2023-09-28 required reviews completed<br>2023-10-04 required reviews completed<br>2023-10-09 required reviews completed<br>2023-10-09 required reviews completed<br>2023-10-10 With Editor<br>2023-10-17 Revise <br>2023-10-30 Revision submitted<br>2023-11-01 With editor<br>2023-11-14 Under review<br>2023-11-24 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73c18483515, createdName=ms8000001640264275, createdTime=Fri Nov 24 09:14:06 CST 2023, time=2023-11-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2194651, encodeId=513d2194651d7, content=请问一下具体的审稿流程，我两个月还在Under Review是没戏了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7e59151108, createdName=ms1000000549465605, createdTime=Fri Mar 22 10:41:04 CST 2024, time=2024-03-22, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2167951, encodeId=258d216e9519b, content=偏重的研究方向：肿瘤<br>经验分享：proof上传之后发现还有地方想改动，可以申请再次proof吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd3c5461670, createdName=ms4000000998812163, createdTime=Sat Nov 11 08:06:25 CST 2023, time=2023-11-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2204874, encodeId=4df022048e459, content=with editor三个月，under review一个月，突然被拒，也不说明具体原因，真是让人无语，浪费时间！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=31495572765, createdName=ms2000001821297625, createdTime=Wed May 15 19:00:43 CST 2024, time=2024-05-15, status=1, ipAttribution=山东省)]
    2024-03-25 X.Dawn 来自浙江省

    medicine返修以后还会拒稿吗，我是OA revise，现在已经with editor快1个月了

    13

    展开13条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2204952, encodeId=be1822049529e, content=偏重的研究方向：Meta分析<br>经验分享：Under review两个月了，还没有一点消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00c59089313, createdName=科研狂人系列, createdTime=Thu May 16 01:34:54 CST 2024, time=2024-05-16, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2161362, encodeId=0b2e216136223, content=偏重的研究方向：肿瘤;case report<br>经验分享：大家的文章在编辑手里待了多久啊，我with editor已经两个多月了。。。别说发表了，连审稿人手都到不了啊，感觉好慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1868855082, createdName=ms8000002119425457, createdTime=Sat Oct 07 16:08:13 CST 2023, time=2023-10-07, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2207103, encodeId=fd42220e10338, content=偏重的研究方向：肿瘤<br>经验分享：细胞或基础实验可以投Medicine吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63569074657, createdName=ms2000000266526934, createdTime=Tue May 28 19:44:36 CST 2024, time=2024-05-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2205315, encodeId=5ef0220531597, content=偏重的研究方向：综合<br>经验分享：Medicine 已见刊 已提交proof 还可以改一点内容吗。不涉及修改数据 就是改一下位置。 就是解释曲线的时候两个指标的生存率写反了。 有人改过吗？medicine是什么态度？<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a><a href='/topic/show?id=cda91148004' target=_blank style='color:#2F92EE;'>#Medicine#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=11480, encryptionId=cda91148004, topicName=Medicine), TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ef29236849, createdName=ms9000001613493042, createdTime=Sat May 18 02:56:29 CST 2024, time=2024-05-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2195248, encodeId=723c219524857, content=medicine返修以后还会拒稿吗，我是OA revise，现在已经with editor快1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=448d5485741, createdName=X.Dawn, createdTime=Mon Mar 25 16:04:17 CST 2024, time=2024-03-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2163624, encodeId=7b2f2163624bc, content=请问各位大佬 这个杂志大概好久能收到proof啊 我10.7号交了版面费 到现在也没有收到proof 有相似情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab278177983, createdName=ms8000001025994613, createdTime=Wed Oct 18 22:27:29 CST 2023, time=2023-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170663, encodeId=07ae21e06633f, content=审稿速度:6.0<br>偏重的研究方向：SEER数据库<br>经验分享：文章接收了，给大家分享一下投稿历程<br>2023-06-27 Submit<br>2023-06-28 Under review 中间时间变过3次，4个审稿人<br>2023-09-28 required reviews completed<br>2023-10-04 required reviews completed<br>2023-10-09 required reviews completed<br>2023-10-09 required reviews completed<br>2023-10-10 With Editor<br>2023-10-17 Revise <br>2023-10-30 Revision submitted<br>2023-11-01 With editor<br>2023-11-14 Under review<br>2023-11-24 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73c18483515, createdName=ms8000001640264275, createdTime=Fri Nov 24 09:14:06 CST 2023, time=2023-11-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2194651, encodeId=513d2194651d7, content=请问一下具体的审稿流程，我两个月还在Under Review是没戏了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7e59151108, createdName=ms1000000549465605, createdTime=Fri Mar 22 10:41:04 CST 2024, time=2024-03-22, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2167951, encodeId=258d216e9519b, content=偏重的研究方向：肿瘤<br>经验分享：proof上传之后发现还有地方想改动，可以申请再次proof吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd3c5461670, createdName=ms4000000998812163, createdTime=Sat Nov 11 08:06:25 CST 2023, time=2023-11-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2204874, encodeId=4df022048e459, content=with editor三个月，under review一个月，突然被拒，也不说明具体原因，真是让人无语，浪费时间！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=31495572765, createdName=ms2000001821297625, createdTime=Wed May 15 19:00:43 CST 2024, time=2024-05-15, status=1, ipAttribution=山东省)]
    2023-10-18 ms8000001025994613

    请问各位大佬 这个杂志大概好久能收到proof啊 我10.7号交了版面费 到现在也没有收到proof 有相似情况的吗

    5

    展开5条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2204952, encodeId=be1822049529e, content=偏重的研究方向：Meta分析<br>经验分享：Under review两个月了，还没有一点消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00c59089313, createdName=科研狂人系列, createdTime=Thu May 16 01:34:54 CST 2024, time=2024-05-16, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2161362, encodeId=0b2e216136223, content=偏重的研究方向：肿瘤;case report<br>经验分享：大家的文章在编辑手里待了多久啊，我with editor已经两个多月了。。。别说发表了，连审稿人手都到不了啊，感觉好慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1868855082, createdName=ms8000002119425457, createdTime=Sat Oct 07 16:08:13 CST 2023, time=2023-10-07, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2207103, encodeId=fd42220e10338, content=偏重的研究方向：肿瘤<br>经验分享：细胞或基础实验可以投Medicine吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63569074657, createdName=ms2000000266526934, createdTime=Tue May 28 19:44:36 CST 2024, time=2024-05-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2205315, encodeId=5ef0220531597, content=偏重的研究方向：综合<br>经验分享：Medicine 已见刊 已提交proof 还可以改一点内容吗。不涉及修改数据 就是改一下位置。 就是解释曲线的时候两个指标的生存率写反了。 有人改过吗？medicine是什么态度？<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a><a href='/topic/show?id=cda91148004' target=_blank style='color:#2F92EE;'>#Medicine#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=11480, encryptionId=cda91148004, topicName=Medicine), TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ef29236849, createdName=ms9000001613493042, createdTime=Sat May 18 02:56:29 CST 2024, time=2024-05-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2195248, encodeId=723c219524857, content=medicine返修以后还会拒稿吗，我是OA revise，现在已经with editor快1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=448d5485741, createdName=X.Dawn, createdTime=Mon Mar 25 16:04:17 CST 2024, time=2024-03-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2163624, encodeId=7b2f2163624bc, content=请问各位大佬 这个杂志大概好久能收到proof啊 我10.7号交了版面费 到现在也没有收到proof 有相似情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab278177983, createdName=ms8000001025994613, createdTime=Wed Oct 18 22:27:29 CST 2023, time=2023-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170663, encodeId=07ae21e06633f, content=审稿速度:6.0<br>偏重的研究方向：SEER数据库<br>经验分享：文章接收了，给大家分享一下投稿历程<br>2023-06-27 Submit<br>2023-06-28 Under review 中间时间变过3次，4个审稿人<br>2023-09-28 required reviews completed<br>2023-10-04 required reviews completed<br>2023-10-09 required reviews completed<br>2023-10-09 required reviews completed<br>2023-10-10 With Editor<br>2023-10-17 Revise <br>2023-10-30 Revision submitted<br>2023-11-01 With editor<br>2023-11-14 Under review<br>2023-11-24 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73c18483515, createdName=ms8000001640264275, createdTime=Fri Nov 24 09:14:06 CST 2023, time=2023-11-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2194651, encodeId=513d2194651d7, content=请问一下具体的审稿流程，我两个月还在Under Review是没戏了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7e59151108, createdName=ms1000000549465605, createdTime=Fri Mar 22 10:41:04 CST 2024, time=2024-03-22, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2167951, encodeId=258d216e9519b, content=偏重的研究方向：肿瘤<br>经验分享：proof上传之后发现还有地方想改动，可以申请再次proof吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd3c5461670, createdName=ms4000000998812163, createdTime=Sat Nov 11 08:06:25 CST 2023, time=2023-11-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2204874, encodeId=4df022048e459, content=with editor三个月，under review一个月，突然被拒，也不说明具体原因，真是让人无语，浪费时间！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=31495572765, createdName=ms2000001821297625, createdTime=Wed May 15 19:00:43 CST 2024, time=2024-05-15, status=1, ipAttribution=山东省)]
    2023-11-24 ms8000001640264275 来自上海

    审稿速度:6.0
    偏重的研究方向：SEER数据库
    经验分享：文章接收了，给大家分享一下投稿历程
    2023-06-27 Submit
    2023-06-28 Under review 中间时间变过3次，4个审稿人
    2023-09-28 required reviews completed
    2023-10-04 required reviews completed
    2023-10-09 required reviews completed
    2023-10-09 required reviews completed
    2023-10-10 With Editor
    2023-10-17 Revise
    2023-10-30 Revision submitted
    2023-11-01 With editor
    2023-11-14 Under review
    2023-11-24 Accept

    21

    展开21条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2204952, encodeId=be1822049529e, content=偏重的研究方向：Meta分析<br>经验分享：Under review两个月了，还没有一点消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00c59089313, createdName=科研狂人系列, createdTime=Thu May 16 01:34:54 CST 2024, time=2024-05-16, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2161362, encodeId=0b2e216136223, content=偏重的研究方向：肿瘤;case report<br>经验分享：大家的文章在编辑手里待了多久啊，我with editor已经两个多月了。。。别说发表了，连审稿人手都到不了啊，感觉好慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1868855082, createdName=ms8000002119425457, createdTime=Sat Oct 07 16:08:13 CST 2023, time=2023-10-07, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2207103, encodeId=fd42220e10338, content=偏重的研究方向：肿瘤<br>经验分享：细胞或基础实验可以投Medicine吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63569074657, createdName=ms2000000266526934, createdTime=Tue May 28 19:44:36 CST 2024, time=2024-05-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2205315, encodeId=5ef0220531597, content=偏重的研究方向：综合<br>经验分享：Medicine 已见刊 已提交proof 还可以改一点内容吗。不涉及修改数据 就是改一下位置。 就是解释曲线的时候两个指标的生存率写反了。 有人改过吗？medicine是什么态度？<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a><a href='/topic/show?id=cda91148004' target=_blank style='color:#2F92EE;'>#Medicine#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=11480, encryptionId=cda91148004, topicName=Medicine), TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ef29236849, createdName=ms9000001613493042, createdTime=Sat May 18 02:56:29 CST 2024, time=2024-05-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2195248, encodeId=723c219524857, content=medicine返修以后还会拒稿吗，我是OA revise，现在已经with editor快1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=448d5485741, createdName=X.Dawn, createdTime=Mon Mar 25 16:04:17 CST 2024, time=2024-03-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2163624, encodeId=7b2f2163624bc, content=请问各位大佬 这个杂志大概好久能收到proof啊 我10.7号交了版面费 到现在也没有收到proof 有相似情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab278177983, createdName=ms8000001025994613, createdTime=Wed Oct 18 22:27:29 CST 2023, time=2023-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170663, encodeId=07ae21e06633f, content=审稿速度:6.0<br>偏重的研究方向：SEER数据库<br>经验分享：文章接收了，给大家分享一下投稿历程<br>2023-06-27 Submit<br>2023-06-28 Under review 中间时间变过3次，4个审稿人<br>2023-09-28 required reviews completed<br>2023-10-04 required reviews completed<br>2023-10-09 required reviews completed<br>2023-10-09 required reviews completed<br>2023-10-10 With Editor<br>2023-10-17 Revise <br>2023-10-30 Revision submitted<br>2023-11-01 With editor<br>2023-11-14 Under review<br>2023-11-24 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73c18483515, createdName=ms8000001640264275, createdTime=Fri Nov 24 09:14:06 CST 2023, time=2023-11-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2194651, encodeId=513d2194651d7, content=请问一下具体的审稿流程，我两个月还在Under Review是没戏了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7e59151108, createdName=ms1000000549465605, createdTime=Fri Mar 22 10:41:04 CST 2024, time=2024-03-22, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2167951, encodeId=258d216e9519b, content=偏重的研究方向：肿瘤<br>经验分享：proof上传之后发现还有地方想改动，可以申请再次proof吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd3c5461670, createdName=ms4000000998812163, createdTime=Sat Nov 11 08:06:25 CST 2023, time=2023-11-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2204874, encodeId=4df022048e459, content=with editor三个月，under review一个月，突然被拒，也不说明具体原因，真是让人无语，浪费时间！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=31495572765, createdName=ms2000001821297625, createdTime=Wed May 15 19:00:43 CST 2024, time=2024-05-15, status=1, ipAttribution=山东省)]
    2024-03-22 ms1000000549465605 来自重庆

    请问一下具体的审稿流程，我两个月还在Under Review是没戏了吗

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2204952, encodeId=be1822049529e, content=偏重的研究方向：Meta分析<br>经验分享：Under review两个月了，还没有一点消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00c59089313, createdName=科研狂人系列, createdTime=Thu May 16 01:34:54 CST 2024, time=2024-05-16, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2161362, encodeId=0b2e216136223, content=偏重的研究方向：肿瘤;case report<br>经验分享：大家的文章在编辑手里待了多久啊，我with editor已经两个多月了。。。别说发表了，连审稿人手都到不了啊，感觉好慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1868855082, createdName=ms8000002119425457, createdTime=Sat Oct 07 16:08:13 CST 2023, time=2023-10-07, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2207103, encodeId=fd42220e10338, content=偏重的研究方向：肿瘤<br>经验分享：细胞或基础实验可以投Medicine吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63569074657, createdName=ms2000000266526934, createdTime=Tue May 28 19:44:36 CST 2024, time=2024-05-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2205315, encodeId=5ef0220531597, content=偏重的研究方向：综合<br>经验分享：Medicine 已见刊 已提交proof 还可以改一点内容吗。不涉及修改数据 就是改一下位置。 就是解释曲线的时候两个指标的生存率写反了。 有人改过吗？medicine是什么态度？<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a><a href='/topic/show?id=cda91148004' target=_blank style='color:#2F92EE;'>#Medicine#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=11480, encryptionId=cda91148004, topicName=Medicine), TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ef29236849, createdName=ms9000001613493042, createdTime=Sat May 18 02:56:29 CST 2024, time=2024-05-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2195248, encodeId=723c219524857, content=medicine返修以后还会拒稿吗，我是OA revise，现在已经with editor快1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=448d5485741, createdName=X.Dawn, createdTime=Mon Mar 25 16:04:17 CST 2024, time=2024-03-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2163624, encodeId=7b2f2163624bc, content=请问各位大佬 这个杂志大概好久能收到proof啊 我10.7号交了版面费 到现在也没有收到proof 有相似情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab278177983, createdName=ms8000001025994613, createdTime=Wed Oct 18 22:27:29 CST 2023, time=2023-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170663, encodeId=07ae21e06633f, content=审稿速度:6.0<br>偏重的研究方向：SEER数据库<br>经验分享：文章接收了，给大家分享一下投稿历程<br>2023-06-27 Submit<br>2023-06-28 Under review 中间时间变过3次，4个审稿人<br>2023-09-28 required reviews completed<br>2023-10-04 required reviews completed<br>2023-10-09 required reviews completed<br>2023-10-09 required reviews completed<br>2023-10-10 With Editor<br>2023-10-17 Revise <br>2023-10-30 Revision submitted<br>2023-11-01 With editor<br>2023-11-14 Under review<br>2023-11-24 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73c18483515, createdName=ms8000001640264275, createdTime=Fri Nov 24 09:14:06 CST 2023, time=2023-11-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2194651, encodeId=513d2194651d7, content=请问一下具体的审稿流程，我两个月还在Under Review是没戏了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7e59151108, createdName=ms1000000549465605, createdTime=Fri Mar 22 10:41:04 CST 2024, time=2024-03-22, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2167951, encodeId=258d216e9519b, content=偏重的研究方向：肿瘤<br>经验分享：proof上传之后发现还有地方想改动，可以申请再次proof吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd3c5461670, createdName=ms4000000998812163, createdTime=Sat Nov 11 08:06:25 CST 2023, time=2023-11-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2204874, encodeId=4df022048e459, content=with editor三个月，under review一个月，突然被拒，也不说明具体原因，真是让人无语，浪费时间！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=31495572765, createdName=ms2000001821297625, createdTime=Wed May 15 19:00:43 CST 2024, time=2024-05-15, status=1, ipAttribution=山东省)]
    2023-11-11 ms4000000998812163 来自湖北省

    偏重的研究方向：肿瘤
    经验分享：proof上传之后发现还有地方想改动，可以申请再次proof吗？

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2204952, encodeId=be1822049529e, content=偏重的研究方向：Meta分析<br>经验分享：Under review两个月了，还没有一点消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00c59089313, createdName=科研狂人系列, createdTime=Thu May 16 01:34:54 CST 2024, time=2024-05-16, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2161362, encodeId=0b2e216136223, content=偏重的研究方向：肿瘤;case report<br>经验分享：大家的文章在编辑手里待了多久啊，我with editor已经两个多月了。。。别说发表了，连审稿人手都到不了啊，感觉好慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1868855082, createdName=ms8000002119425457, createdTime=Sat Oct 07 16:08:13 CST 2023, time=2023-10-07, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2207103, encodeId=fd42220e10338, content=偏重的研究方向：肿瘤<br>经验分享：细胞或基础实验可以投Medicine吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63569074657, createdName=ms2000000266526934, createdTime=Tue May 28 19:44:36 CST 2024, time=2024-05-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2205315, encodeId=5ef0220531597, content=偏重的研究方向：综合<br>经验分享：Medicine 已见刊 已提交proof 还可以改一点内容吗。不涉及修改数据 就是改一下位置。 就是解释曲线的时候两个指标的生存率写反了。 有人改过吗？medicine是什么态度？<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a><a href='/topic/show?id=cda91148004' target=_blank style='color:#2F92EE;'>#Medicine#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=11480, encryptionId=cda91148004, topicName=Medicine), TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ef29236849, createdName=ms9000001613493042, createdTime=Sat May 18 02:56:29 CST 2024, time=2024-05-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2195248, encodeId=723c219524857, content=medicine返修以后还会拒稿吗，我是OA revise，现在已经with editor快1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=448d5485741, createdName=X.Dawn, createdTime=Mon Mar 25 16:04:17 CST 2024, time=2024-03-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2163624, encodeId=7b2f2163624bc, content=请问各位大佬 这个杂志大概好久能收到proof啊 我10.7号交了版面费 到现在也没有收到proof 有相似情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab278177983, createdName=ms8000001025994613, createdTime=Wed Oct 18 22:27:29 CST 2023, time=2023-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170663, encodeId=07ae21e06633f, content=审稿速度:6.0<br>偏重的研究方向：SEER数据库<br>经验分享：文章接收了，给大家分享一下投稿历程<br>2023-06-27 Submit<br>2023-06-28 Under review 中间时间变过3次，4个审稿人<br>2023-09-28 required reviews completed<br>2023-10-04 required reviews completed<br>2023-10-09 required reviews completed<br>2023-10-09 required reviews completed<br>2023-10-10 With Editor<br>2023-10-17 Revise <br>2023-10-30 Revision submitted<br>2023-11-01 With editor<br>2023-11-14 Under review<br>2023-11-24 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73c18483515, createdName=ms8000001640264275, createdTime=Fri Nov 24 09:14:06 CST 2023, time=2023-11-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2194651, encodeId=513d2194651d7, content=请问一下具体的审稿流程，我两个月还在Under Review是没戏了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7e59151108, createdName=ms1000000549465605, createdTime=Fri Mar 22 10:41:04 CST 2024, time=2024-03-22, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2167951, encodeId=258d216e9519b, content=偏重的研究方向：肿瘤<br>经验分享：proof上传之后发现还有地方想改动，可以申请再次proof吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd3c5461670, createdName=ms4000000998812163, createdTime=Sat Nov 11 08:06:25 CST 2023, time=2023-11-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2204874, encodeId=4df022048e459, content=with editor三个月，under review一个月，突然被拒，也不说明具体原因，真是让人无语，浪费时间！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=31495572765, createdName=ms2000001821297625, createdTime=Wed May 15 19:00:43 CST 2024, time=2024-05-15, status=1, ipAttribution=山东省)]
    2024-05-15 ms2000001821297625 来自山东省

    with editor三个月，under review一个月，突然被拒，也不说明具体原因，真是让人无语，浪费时间！

    4

    展开4条回复
共500条页码: 1/50页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分